Guaifenesin Tablet, Extended Release
Product Images NDC 41415-996

1 FDA label image from Publix Super Markets, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 41415-996). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Publix Super Markets, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 extended-release Tablets Blister Pack Carton)

Principal Display Panel (20 extended-release Tablets Blister Pack Carton)
GUAIFENESIN extended-release tablets, 600 mg, oral dosage form, labeled as expectorant for 12-hour mucus relief. The packaging contains 20 extended-release tablets, marketed by Publix Super Markets, Inc. The label highlights relief of chest congestion and thinning of mucus.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.